Drug Search Results
More Filters [+]

Cobiprostone

Alternative Names: cobiprostone
Latest Update: 2019-11-22
Latest Update Note: Clinical Trial Update

Product Description

Mechanisms of Action: Voltage-Gated Chlorine Channel Binder

Novel Mechanism: Yes

Modality: Small Molecule

Route of Administration: Oral

FDA Designation: None *

Approval Status: Not Approved

Approved Countries: None

Approved Indications: None

Known Adverse Events: None

Company: Mallinckrodt
Company Location:
Company CEO:
Additonal Commercial Interests: None

Clinical Description

Map of Global Clinical Trials for Cobiprostone

Countries in Clinic:

Active Clinical Trial Count:

Highest Development Phases

Phase 2: Duodenal Ulcer|Osteoarthritis|Stomatitis|Arthritis, Rheumatoid|Hypertension, Portal|Mucositis|Head and Neck Cancer

Trial

Phase

Trial Status

Disease

Primary Completion Date

Probability of Success

SCMP-8811-202

P2

Terminated

Stomatitis|Head and Neck Cancer|Mucositis

2016-07-01

23%

SU0621

P2

Completed

Osteoarthritis|Arthritis, Rheumatoid|Duodenal Ulcer

2009-04-01

SPH0721

P2

Terminated

Hypertension, Portal

2009-02-01

JapicCTI-152763

P2

Completed

Unknown

None

Recent News Events

Date

Type

Title